Psoriasis drug may help hearts, study finds
Disease control
Completed
This study tested whether tildrakizumab, an FDA-approved psoriasis medication, can improve blood flow to the heart in people with moderate-to-severe psoriasis. 36 adults with psoriasis and heart disease risk took the drug for 6 months. Researchers used heart scans to measure chan…
Phase: PHASE4 • Sponsor: Marcelo F. Di Carli, MD, FACC • Aim: Disease control
Last updated May 07, 2026 18:42 UTC